ResMed Inc. (0KW4.L)
USD 212.7
(2.48%)
USD 212.7
(2.48%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 635.57 Million USD | -52.99% |
| 2023 | 1.35 Billion USD | 109.99% |
| 2022 | 643.84 Million USD | 29.17% |
| 2021 | 498.43 Million USD | -40.39% |
| 2020 | 836.1 Million USD | -25.6% |
| 2019 | 1.12 Billion USD | 1111.52% |
| 2018 | 92.75 Million USD | -63.86% |
| 2017 | 256.67 Million USD | -42.13% |
| 2016 | 443.56 Million USD | 206.46% |
| 2015 | -416.65 Million USD | 31.12% |
| 2014 | -604.94 Million USD | -5.16% |
| 2013 | -575.26 Million USD | -2.96% |
| 2012 | -558.7 Million USD | 12.03% |
| 2011 | -635.1 Million USD | -73.01% |
| 2010 | -367.08 Million USD | -44.57% |
| 2009 | -253.91 Million USD | -38.43% |
| 2008 | -183.42 Million USD | -29.36% |
| 2007 | -141.79 Million USD | -44.01% |
| 2006 | -98.46 Million USD | -405.94% |
| 2005 | 32.18 Million USD | 305.56% |
| 2004 | -15.65 Million USD | -1161.64% |
| 2003 | -1.24 Million USD | -102.46% |
| 2002 | 50.39 Million USD | -54.13% |
| 2001 | 109.86 Million USD | 701.99% |
| 2000 | -18.25 Million USD | -64.41% |
| 1999 | -11.1 Million USD | 27.45% |
| 1998 | -15.3 Million USD | -80.0% |
| 1997 | -8.5 Million USD | -84.78% |
| 1996 | -4.6 Million USD | -84.0% |
| 1995 | -2.5 Million USD | 24.24% |
| 1994 | -3.3 Million USD | -135.71% |
| 1993 | -1.4 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 FY | 635.57 Million USD | -52.99% |
| 2024 Q1 | 1.28 Billion USD | -4.84% |
| 2024 Q2 | 1.18 Billion USD | -8.19% |
| 2024 Q4 | 635.57 Million USD | -31.62% |
| 2024 Q3 | 929.53 Million USD | -21.3% |
| 2023 Q3 | 1.49 Billion USD | -11.27% |
| 2023 FY | 1.35 Billion USD | 109.99% |
| 2023 Q1 | 723.46 Million USD | 12.37% |
| 2023 Q2 | 1.68 Billion USD | 133.08% |
| 2023 Q4 | 1.35 Billion USD | -9.64% |
| 2022 Q3 | 630.31 Million USD | -1.88% |
| 2022 Q1 | 673.95 Million USD | 35.21% |
| 2022 Q2 | 642.38 Million USD | -4.68% |
| 2022 FY | 643.84 Million USD | 29.17% |
| 2022 Q4 | 643.84 Million USD | 2.15% |
| 2021 Q1 | 767.52 Million USD | -8.2% |
| 2021 FY | 498.43 Million USD | -40.39% |
| 2021 Q2 | 709.94 Million USD | -7.5% |
| 2021 Q3 | 638.16 Million USD | -10.11% |
| 2021 Q4 | 498.43 Million USD | -21.9% |
| 2020 FY | 836.1 Million USD | -25.6% |
| 2020 Q2 | 1.19 Billion USD | 5.42% |
| 2020 Q3 | 1.15 Billion USD | -3.42% |
| 2020 Q4 | 836.1 Million USD | -27.55% |
| 2020 Q1 | 1.13 Billion USD | 0.86% |
| 2019 Q1 | 299.42 Million USD | 222.82% |
| 2019 Q3 | 1.18 Billion USD | 13.47% |
| 2019 Q2 | 1.04 Billion USD | 250.01% |
| 2019 Q4 | 1.12 Billion USD | -5.5% |
| 2019 FY | 1.12 Billion USD | 1111.52% |
| 2018 Q1 | 207.76 Million USD | -19.05% |
| 2018 Q4 | 92.75 Million USD | -12.26% |
| 2018 Q3 | 105.71 Million USD | -34.02% |
| 2018 FY | 92.75 Million USD | -63.86% |
| 2018 Q2 | 160.23 Million USD | -22.88% |
| 2017 Q2 | 380.35 Million USD | -2.84% |
| 2017 Q1 | 391.47 Million USD | -11.74% |
| 2017 Q4 | 256.67 Million USD | -24.74% |
| 2017 FY | 256.67 Million USD | -42.13% |
| 2017 Q3 | 341.04 Million USD | -10.34% |
| 2016 Q4 | 443.56 Million USD | 256.8% |
| 2016 FY | 443.56 Million USD | 206.46% |
| 2016 Q2 | -257.22 Million USD | 19.98% |
| 2016 Q1 | -321.46 Million USD | 22.85% |
| 2016 Q3 | -282.88 Million USD | -9.97% |
| 2015 Q1 | -505.99 Million USD | 16.36% |
| 2015 FY | -416.65 Million USD | 31.12% |
| 2015 Q2 | -431.03 Million USD | 14.81% |
| 2015 Q3 | -405.74 Million USD | 5.87% |
| 2015 Q4 | -416.65 Million USD | -2.69% |
| 2014 FY | -604.94 Million USD | -5.16% |
| 2014 Q1 | -615.76 Million USD | -7.04% |
| 2014 Q3 | -542.76 Million USD | -1.1% |
| 2014 Q4 | -604.94 Million USD | -11.46% |
| 2014 Q2 | -536.86 Million USD | 12.81% |
| 2013 Q2 | -657.42 Million USD | -5.22% |
| 2013 Q1 | -624.79 Million USD | -11.83% |
| 2013 Q4 | -575.26 Million USD | 14.38% |
| 2013 FY | -575.26 Million USD | -2.96% |
| 2013 Q3 | -671.88 Million USD | -2.2% |
| 2012 Q3 | -540.08 Million USD | -8.72% |
| 2012 Q4 | -558.7 Million USD | -3.45% |
| 2012 Q2 | -496.78 Million USD | -4.37% |
| 2012 FY | -558.7 Million USD | 12.03% |
| 2012 Q1 | -475.96 Million USD | 25.06% |
| 2011 FY | -635.1 Million USD | -73.01% |
| 2011 Q2 | -551.84 Million USD | -23.68% |
| 2011 Q3 | -591.46 Million USD | -7.18% |
| 2011 Q4 | -635.1 Million USD | -7.38% |
| 2011 Q1 | -446.2 Million USD | -21.55% |
| 2010 FY | -367.08 Million USD | -44.57% |
| 2010 Q2 | -306.3 Million USD | 2.58% |
| 2010 Q1 | -314.43 Million USD | -23.84% |
| 2010 Q3 | -377.23 Million USD | -23.16% |
| 2010 Q4 | -367.08 Million USD | 2.69% |
| 2009 Q4 | -253.91 Million USD | -51.6% |
| 2009 FY | -253.91 Million USD | -38.43% |
| 2009 Q3 | -167.49 Million USD | 0.05% |
| 2009 Q2 | -167.58 Million USD | -6.78% |
| 2009 Q1 | -156.94 Million USD | 14.43% |
| 2008 Q4 | -183.42 Million USD | -4.64% |
| 2008 Q2 | -145.87 Million USD | -7.74% |
| 2008 Q1 | -135.39 Million USD | 4.51% |
| 2008 FY | -183.42 Million USD | -29.36% |
| 2008 Q3 | -175.28 Million USD | -20.16% |
| 2007 Q4 | -141.79 Million USD | -12.95% |
| 2007 FY | -141.79 Million USD | -44.01% |
| 2007 Q3 | -125.53 Million USD | -26.65% |
| 2007 Q2 | -99.12 Million USD | -22.6% |
| 2007 Q1 | -80.84 Million USD | 17.89% |
| 2006 Q2 | 63.29 Million USD | 15.57% |
| 2006 Q3 | -69.68 Million USD | -210.09% |
| 2006 Q4 | -98.46 Million USD | -41.29% |
| 2006 FY | -98.46 Million USD | -405.94% |
| 2006 Q1 | 54.77 Million USD | 70.18% |
| 2005 Q4 | 32.18 Million USD | 237.25% |
| 2005 Q3 | -23.45 Million USD | 21.36% |
| 2005 Q2 | -29.81 Million USD | -5.1% |
| 2005 Q1 | -28.37 Million USD | -81.2% |
| 2005 FY | 32.18 Million USD | 305.56% |
| 2004 FY | -15.65 Million USD | -1161.64% |
| 2004 Q4 | -15.65 Million USD | -1087.94% |
| 2004 Q3 | -1.31 Million USD | -115.75% |
| 2004 Q2 | 8.36 Million USD | -2.4% |
| 2004 Q1 | 8.57 Million USD | 790.81% |
| 2003 Q3 | 19.53 Million USD | -36.54% |
| 2003 FY | -1.24 Million USD | -102.46% |
| 2003 Q2 | 30.78 Million USD | -31.11% |
| 2003 Q1 | 44.68 Million USD | -11.33% |
| 2003 Q4 | -1.24 Million USD | -106.35% |
| 2002 Q2 | 115.95 Million USD | -3.01% |
| 2002 Q3 | 89.77 Million USD | -22.58% |
| 2002 Q4 | 50.39 Million USD | -43.87% |
| 2002 FY | 50.39 Million USD | -54.13% |
| 2002 Q1 | 119.55 Million USD | 8.82% |
| 2001 Q2 | -12.35 Million USD | -86.66% |
| 2001 Q1 | -6.62 Million USD | 63.73% |
| 2001 FY | 109.86 Million USD | 701.99% |
| 2001 Q4 | 109.86 Million USD | 116.03% |
| 2001 Q3 | 50.85 Million USD | 511.56% |
| 2000 Q2 | -11.5 Million USD | -6.48% |
| 2000 FY | -18.25 Million USD | -64.41% |
| 2000 Q1 | -10.8 Million USD | 2.7% |
| 2000 Q4 | -18.25 Million USD | -11.58% |
| 2000 Q3 | -16.35 Million USD | -42.23% |
| 1999 Q3 | -10.7 Million USD | 20.74% |
| 1999 FY | -11.1 Million USD | 27.45% |
| 1999 Q1 | -16.3 Million USD | -6.54% |
| 1999 Q2 | -13.5 Million USD | 17.18% |
| 1999 Q4 | -11.1 Million USD | -3.74% |
| 1998 Q4 | -15.3 Million USD | -33.04% |
| 1998 FY | -15.3 Million USD | -80.0% |
| 1998 Q2 | -7.2 Million USD | 43.75% |
| 1998 Q3 | -11.5 Million USD | -59.72% |
| 1998 Q1 | -12.8 Million USD | -50.59% |
| 1997 Q3 | -7.9 Million USD | 0.0% |
| 1997 FY | -8.5 Million USD | -84.78% |
| 1997 Q1 | -5.6 Million USD | -21.74% |
| 1997 Q2 | -7.9 Million USD | -41.07% |
| 1997 Q4 | -8.5 Million USD | -7.59% |
| 1996 FY | -4.6 Million USD | -84.0% |
| 1996 Q3 | -3.1 Million USD | 0.0% |
| 1996 Q4 | -4.6 Million USD | -48.39% |
| 1995 FY | -2.5 Million USD | 24.24% |
| 1995 Q4 | -2.5 Million USD | 0.0% |
| 1994 FY | -3.3 Million USD | -135.71% |
| 1994 Q4 | -3.3 Million USD | 0.0% |
| 1993 Q4 | -1.4 Million USD | 0.0% |
| 1993 FY | -1.4 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Phreesia, Inc. | -75.53 Million USD | 941.408% |
| Accuray Incorporated | 103.58 Million USD | -513.571% |
| Align Technology, Inc. | -840.47 Million USD | 175.621% |
| Elevance Health Inc. | 18.59 Billion USD | 96.582% |
| AxoGen, Inc. | 32.26 Million USD | -1869.795% |
| Boston Scientific Corporation | 8.23 Billion USD | 92.279% |
| CVS Health Corporation | 71.18 Billion USD | 99.107% |
| Cardinal Health, Inc. | 476 Million USD | -33.524% |
| Centene Corporation | 506 Million USD | -25.608% |
| DaVita Inc. | 10.65 Billion USD | 94.033% |
| HCA Healthcare, Inc. | 40.92 Billion USD | 98.447% |
| Hologic, Inc. | 374.4 Million USD | -69.758% |
| Humana Inc. | 5.51 Billion USD | 88.484% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | -28.672% |
| Laboratory Corporation of America Holdings | 5.41 Billion USD | 88.268% |
| Masimo Corporation | 804 Million USD | 20.949% |
| McKesson Corporation | 889 Million USD | 28.507% |
| Patterson Companies, Inc. | 648.47 Million USD | 1.99% |
| Quest Diagnostics Incorporated | 4.68 Billion USD | 86.428% |
| Henry Schein, Inc. | 2.57 Billion USD | 75.269% |
| Teladoc Health, Inc. | 468.6 Million USD | -35.632% |
| Universal Health Services, Inc. | 5.24 Billion USD | 87.887% |
| Veeva Systems Inc. | -647.71 Million USD | 198.126% |
| Baxter International Inc. | 11.16 Billion USD | 94.308% |
| Becton, Dickinson and Company | 14.46 Billion USD | 95.606% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 123.891% |
| Danaher Corporation | 13.49 Billion USD | 95.289% |
| Stryker Corporation | 10.02 Billion USD | 93.659% |
| Medtronic plc | 23.67 Billion USD | 97.316% |